COMMUNIQUÉS West-GlobeNewswire

-
HNL Lab Medicine Opens New Location at Tower Place in Bethlehem
21/07/2025 -
UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar
21/07/2025 -
Second Circuit Affirms Dismissal of Complaint Against Vystar In the Case Of EMA Financial LLC v. Vystar Corp.
21/07/2025 -
Natural Appetite Suppressant: Why More Are Choosing PhenQ Over Weight Loss Injections for Safer Weight Management Results in 2025
21/07/2025 -
CARBIOS enters the r-PET market for tire textile filaments
21/07/2025 -
CARBIOS entre dans le marché du r-PET destiné aux filaments textiles pour pneumatiques
21/07/2025 -
REPEAT – Health care advocates afraid of major cuts and privatization hold shadow summit and rally at Council of the Federation next week
21/07/2025 -
Foundation for Sarcoidosis Research Sarc Fighter Podcast Surpasses 100,000 Downloads, Amplifying Voices in the Sarcoidosis Community
21/07/2025 -
Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies
21/07/2025 -
Acentra Health Names Marnie Keogh as Senior Vice President of Marketing
21/07/2025 -
Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin
21/07/2025 -
Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease
21/07/2025 -
Sharecare introduces Condition Masterclass to support patient education and health literacy for chronic disease management
21/07/2025 -
Spirair Receives FDA Clearance for TurbAlign, a New Bioabsorbable Implant That Helps Keep Nasal Passages Open After Sinus Surgery
21/07/2025 -
VitalHub Announces Q2 2025 Conference Call Date
21/07/2025 -
Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq
21/07/2025 -
Kaida BioPharma Chairman and Founding Investor, Craig Pierson, to Present at Opal Group’s Family Office & Private Wealth Management Forum 2025
21/07/2025 -
Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market
21/07/2025 -
Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum
21/07/2025
Pages